Journal: Cell Death Discovery
Article Title: Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases
doi: 10.1038/s41420-022-01090-6
Figure Lengend Snippet: a , b Representative tissue microarray data of STC2 in clinical specimens ( a , GL2082; b , GL208, Biomax). The scale bar represents 100 µm. STC2 staining score from 0-4 were analyzed in different tissues. N, normal tissues; A, astrocytoma; GBM, glioblastoma. One-way ANOVA, * p < 0.05, ** p < 0.01, *** p < 0.001, n.s., no significance. c The levels of STC2 mRNA expression in low grade glioma (LGG) versus glioblastoma (GBM) tissues obtained from TCGA Research Network were analyzed. Unpaired t-test, ** p < 0.01. d The mRNA expression of STC2 in various glioblastoma cell lines were analyzed. After normalizing with 18 S rRNA in each sample, the relative mRNA levels were calculated using A172 = 1. Means ± SD; n = 3 biological replicates. Oneway ANOVA, ** p < 0.01, *** p < 0.001, n.s., no significance. e , f Representative images of Western blotting against STC2 and β-ACTIN in whole lysates of glioblastoma cell lines ( e ) and concentrated culture media (Conditioned media CM) ( f ).
Article Snippet: Brain primary tumor tissue microarray slides (Cat# GL208 and GL2082) were purchased from US Biomax, Inc. (MD, USA).
Techniques: Microarray, Staining, Expressing, Western Blot